PC3001 - ENT, Eyes and Respiratory Pharmacy
|Student Contribution Band:
||College of Medicine & Dentistry
Available to level 3 Bachelor of Pharmacy students.
Respiratory infections and eye problems are two common presentations in pharmacy practice.
This subject builds upon knowledge of the anatomy, physiology, pathophysiology and
pharmacotherapeutics in the areas of ophthalmology, ear, nose, throat, oral and respiratory
pharmacy. The student will learn the pharmaceutics of formulations and dosage forms
used to treat ear, nose, throat, eye, dental and respiratory conditions. An emphasis
will be placed on the appropriate use of Pharmacy (S2) and Pharmacists Only (S3) medications;
medical appliances; audiological conditions among indigenous populations; and the
treatment and prevention of common disorders in these sensory/body systems.
- describe the common clinical presentation and management of conditions of the ear,
nose, throat, eye, mouth and respiratory system, especially the use of Pharmacy and
Pharmacist Only medications and the use of medical devices in treating these conditions;
- develop an understanding of the principles of rational drug use in the treatment of
- discuss the complexities of managing these conditions in rural and remote areas;
- outline the pathophysiology and therapeutics of respiratory conditions, including
upper respiratory tract infections, acute and chronic conditions and preventative
- outline the pathophysiology and therapeutics of ophthalmological, nasal and aural
conditions including audiological conditions found in Indigenous communities;
- describe the pharmaceutics of pharmaceutical formulations and dosage forms used in
ophthalmology, ENT and respiratory conditions.
- end of semester exam (60%)
- oral exam (osce) (25%)
- on-course assessment (15%).
||All level 2 BPharm subjects
|PP2231 and PP3251 and PP3252
Minor variations might occur due to the continuous Subject quality improvement process,
and in case
of minor variation(s) in assessment details, the Subject Outline represents the latest